Expectations were about $1.03 of adjusted EPS and $1.22 billion of revenue; ATI delivered above both. The published consensus called for roughly $1.03 of EPS and $1.22 billion of revenue, versus actual adjusted EPS of $1.23 and sales of $1.261 billion.
| ($ millions except per-share amounts) | Q2 2026 | Q1 2026 | Q2 2025 | Published expectation |
|---|---|---|---|---|
| Sales | $1,261.1 | $1,151.5 | $1,140.4 | ~$1,220 |
| Adjusted EPS | $1.23 | $1.00 | $0.74 | ~$1.03 |
| Adjusted EBITDA | $284.4 | $231.7 | $207.7 | — |
| Adjusted EBITDA margin | 22.6% | 20.1% | 18.2% | — |
| Adjusted free cash flow | $68.6 | — | $92.9 | — |
The beat was operational, not just headline-driven. Adjusted EBITDA rose 37% year over year on 11% sales growth, while margin expanded to 22.6% (Financial Highlights). Advanced Alloys & Solutions was the main accelerator: segment EBITDA increased to $147.6 million from $97.0 million sequentially, with margin rising to 23.7% from 18.1% (Segment results — Advanced Alloys & Solutions). High Performance Materials & Components grew more modestly, and its margin slipped to 24.1% from 24.9% because of higher manufacturing and qualification costs (Segment results — High Performance Materials & Components).
The most important change is the raised full-year outlook, which moves the market’s earnings baseline higher. Full-year adjusted EBITDA guidance increased to $1.135-$1.185 billion from $1.010-$1.060 billion, while adjusted EPS guidance rose to $4.90-$5.18 from $4.20-$4.48 (Guidance). ATI also introduced Q3 guidance of $305-$315 million of adjusted EBITDA and $1.31-$1.37 of adjusted EPS, implying another step up from Q2. The filing attributes the increase to pricing, richer mix and added capacity, but the quarter’s strong aerospace and defense demand provides tangible support: aerospace and defense sales rose 13% year over year to $862.0 million, including a 36% increase in defense sales (End-market sales).
The read is strongly positive, although cash conversion and recurring-cost quality keep it from being flawless. Q2 adjusted free cash flow fell to $68.6 million from $92.9 million year over year, while managed working capital consumed $128.9 million during the quarter and climbed to 34.3% of annualized sales from 32.5% at year-end (Adjusted Free Cash Flow; Managed Working Capital). Results also included a $9.9 million facility-sale gain and $23.6 million of excluded special-item charges, including start-up, transformation and restructuring costs (Non-GAAP reconciliations). Those items temper the quality of the quarter, but they do not offset the clear EPS and revenue beat or the substantial guidance increase.
Read the original 8-K on SEC EDGAR ↗